CareDx (CDNA) Tops Q1 EPS by 14c; Raises Revenue Guidance

CareDx (NASDAQ: CDNA) reported Q1 EPS of $0.14, $0.14 better than the analyst estimate of $0.00. Revenue for the quarter came in at $67.4 million versus the consensus estimate of $61.05 million.

GUIDANCE:

CareDx sees FY2021 revenue of $270-280 million, versus the consensus of $260.92 million.

For earnings history and earnings-related data on CareDx (CDNA) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• Cerebras Systems posts 94% revenue jump, announces OpenAI deal
• Cerebras Systems (CBRS) Misses Q1 EPS, Revenues Beat